Shedir Pharma Srl Unipersonale banner

Shedir Pharma Srl Unipersonale
MIL:SHE

Watchlist Manager
Shedir Pharma Srl Unipersonale Logo
Shedir Pharma Srl Unipersonale
MIL:SHE
Watchlist
Price: 4.88 EUR
Market Cap: €55.8m

Wall St Price Targets

SHE Price Targets Summary
Shedir Pharma Srl Unipersonale

There are no price targets for SHE.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Shedir Pharma Srl Unipersonale Competitors:
Price Targets

Revenue
Forecast

5% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
5% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 5 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 4 years is 8%.

Gross Profit
Forecast

3% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-26%
Average Miss
3% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-26%
Average Miss

Over the last 5 years, the compound annual growth rate for Gross Profit has been 3%.

Operating Income
Forecast

-2% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
-2% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 5 years, the compound annual growth rate for Operating Income has been -2%. The projected CAGR for the next 4 years is 8%.

Pre-Tax Income
Forecast

-2% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
-2% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 5 years, the compound annual growth rate for Pre-Tax Income has been -2%.

Net Income
Forecast

-3% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
-3% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 5 years, the compound annual growth rate for Net Income has been -3%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is SHE's stock price target?
Not Available

SHE does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Shedir Pharma Srl Unipersonale?
Projected CAGR
8%

Over the last 5 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 4 years is 8%.

What is the Operating Income forecast for Shedir Pharma Srl Unipersonale?
Projected CAGR
8%

Over the last 5 years, the compound annual growth rate for Operating Income has been -2%. The projected CAGR for the next 4 years is 8%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett